Palforzia Peanut Allergy Immunotherapy: Aimmune CEO On REMS Restrictions, Manufacturing

 
• By Brenda Sandburg

Aimmune CEO Jayson Dallas tells the Pink Sheet how physicians and patients are being certified to use Palforzia and how the product's food-based manufacturing process is actually an advantage. 

Peanut allergy.
Palforzia peanut allergy immunotherpay launch involves new challenges

More from Drug Safety

More from Pink Sheet